English, PDF, 439kb
The Luxembourg health care system achieves good results relatively efficiently. Luxembourg is, however, lagging behind other OECD countries with high volume of antibiotics prescribed and high rates of avoidable hospital admissions. Population ageing and increasing risk factors are other important challenges that demand further scrutiny.
This report presents the findings of a research project to investigate the drivers and criteria shaping the application of genomic biotechnology to health in different national settings, and the barriers to implementation nationally and internationally. Findings are based on case studies on Finland, Israel, Luxembourg, Mexico, the United Kingdom, China and South Africa.
The mortality amenable to health care is defined as a possible indicator to measure the health care systems performance in preventing premature deaths that can be avoided by appropriate health care intervention. This paper assesses the feasibility of using this indicator in OECD countries.